Personal information

Websites & social links

Instituto Investigación Sanitaria Puerta de Hierro (IDIPHIM)

Activities

Collapse all

Employment (5)

Fundación para la Investigación Biomédica del Hospital Universitario Puerta de Hierro Majalahonda: Majadahonda, Comunidad de Madrid, ES

2013-04-11 to present | Scientific coordinator (​Technical Support Units)
Employment
Source: Self-asserted source
Margarita Sanchez-Beato

Fundación para la Investigación Biomédica del Hospital Universitario Puerta de Hierro Majalahonda: Majadahonda, Comunidad de Madrid, ES

2012-10-01 to present | Group Leader (Lymphoma research group)
Employment
Source: Self-asserted source
Margarita Sanchez-Beato

Spanish National Cancer Research Centre (CNIO): Madrid, Madrid, ES

2000-03-01 to 2012-01-15 | Researcher (Molecular Pathology)
Employment
Source: Self-asserted source
Margarita Sanchez-Beato

Complejo Hospitalario de Toledo: Toledo, Castilla-La Mancha, ES

1998-06 to 2000-03 | PhD fellowship (Pathology/Genetics)
Employment
Source: Self-asserted source
Margarita Sanchez-Beato

Complejo Hospitalario de Toledo: Toledo, Castilla-La Mancha, ES

1992-01 to 1998-06 | PhD student (Pathology/Genetics)
Employment
Source: Self-asserted source
Margarita Sanchez-Beato

Education and qualifications (3)

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

1997 | Phd (Biochemistry and Molecular Biology)
Education
Source: Self-asserted source
Margarita Sanchez-Beato

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

1988 to 1990 | BsC (Chemistry/Biochemistry and Molecular Biology)
Education
Source: Self-asserted source
Margarita Sanchez-Beato

Universidad de Castilla-La Mancha - Campus de Toledo: Toledo, Castilla-La Mancha, ES

1985 to 1988 | - (Chemistry)
Education
Source: Self-asserted source
Margarita Sanchez-Beato

Professional activities (6)

GOTEL: MADRID, Madrid, ES

Associate
Membership
Source: Self-asserted source
Margarita Sanchez-Beato

ASEICA: Madrid, ES

associate
Membership
Source: Self-asserted source
Margarita Sanchez-Beato

European Association For Cancer Research: Nottingham, Nottingham, GB

2021-04-30 to present
Membership
Source: Self-asserted source
Margarita Sanchez-Beato

Fundación para la Investigación Biomédica del Hospital Universitario Puerta de Hierro Majalahonda: Majadahonda, Comunidad de Madrid, ES

2020 to 2024 | Vocal ((Innovation Committee)
Service
Source: Self-asserted source
Margarita Sanchez-Beato

Centro de Investigación Biomédica en Red de Cáncer: Madrid, Comunidad de Madrid, ES

2020 to 2023
Membership
Source: Self-asserted source
Margarita Sanchez-Beato

Fundación para la Investigación Biomédica del Hospital Universitario Puerta de Hierro Majalahonda: Majadahonda, Comunidad de Madrid, ES

2012 to 2020 | Secretary (Comisión Investigacion)
Service
Source: Self-asserted source
Margarita Sanchez-Beato

Funding (9)

Multi-omic signature in liquid biopsy for genetic stratification and prediction of response to immunochemotherapy in aggressive B-cell lymphoma (BLinfoPred).

2024-11 to 2027-10 | Grant
Agencia Estatal de Investigación (Madrid, ES)
GRANT_NUMBER:

CPP2023-010616
Source: Self-asserted source
Margarita Sanchez-Beato

Microenvironment in Follicular Lymphoma: crosstalk with tumoral B-cells and its relevance in disease progression and histological transformation

2024-01 to 2026-12 | Grant
ISCIII (Madrid, ES)
GRANT_NUMBER:

PI23/01587
Source: Self-asserted source
Margarita Sanchez-Beato

3D cell cultures for precision medicine in aggressive B-cell lymphoma

2021-01 to 2023-12 | Grant
ISCIII (Madrid, ES)
GRANT_NUMBER:

PI20/0591
Source: Self-asserted source
Margarita Sanchez-Beato

CAN LIQUID BIOPSY HELP TO PREDICT TREATMENT RESPONSE IN PATIENTS WITH AGGRESSIVE B-CELL LYMPHOMAS?

2019-03 to 2021-03 | Contract
GILEAD SPAIN (Madrid, ES)
GRANT_NUMBER:

GLD18/00019
Source: Self-asserted source
Margarita Sanchez-Beato

AGGRESSIVE LYMPHOMAS, INTEGRATED CLINICAL AND GENOMIC ANALYSIS FOR PRECISION MEDICINE

2018-01 to 2021-12 | Grant
Consejería de Educación, Juventud y Deporte, Comunidad de Madrid (Madrid, ES)
Part of GRANT_NUMBER:

B2017/BMD3778
Source: Self-asserted source
Margarita Sanchez-Beato

TESTING NEW DRUGS FOR PRECISION MEDICINE IN RITUXIMAB RELAPSED / REFRACTORY AGGRESSIVE B-CELL LYMPHOMA: A COMPREHENSIVE ANALYSIS

2018-01 to 2020-12 | Grant
ISCIII (Madrid, ES)
GRANT_NUMBER:

PI17/00272
Source: Self-asserted source
Margarita Sanchez-Beato

METHOD TO PREDICT RISK OF TRANSFORMATION IN PATIENTS WITH FOLICULAR LYMPHOMAR

2018-01 to 2019-12 | Grant
Instituto de Salud Carlos III (Madrid, Madrid, ES)
GRANT_NUMBER:

DTS17/00039
Source: Self-asserted source
Margarita Sanchez-Beato

HETEROGENEITY AND CLONAL EVOLUTION IN TRANSFORMATION AND TREATMENT ESCAPE IN DIFFUSE LARGE B-CELL LYMPHOMA

2015-01 to 2017-12 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI14/00221
Source: Self-asserted source
Margarita Sanchez-Beato

Miguel Servet

2012-01 to 2020-01 | Salary award
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

CP11/00018-CPII16/00024
Source: Self-asserted source
Margarita Sanchez-Beato

Works (50 of 104)

Items per page:
Page 1 of 3

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial

Cancers
2025-02 | Journal article | Author
DOI: 10.3390/cancers17030532
Contributors: Sara Fernández-Castillejo; Joan Badia; Luis de la Cruz-Merino; Alejandro Martín García-Sancho; Fernando Carnicero-González; Natalia Palazón Carrión; Eduardo Ríos-Herranz; Fátima de la Cruz-Vicente; ANTONIO RUEDA DOMINGUEZ; Natividad Martínez-Banaclocha et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2024-05-17 | Journal article | Author
DOI: 10.1016/j.modpat.2024.100516
PMID: 38763418
Contributors: Fernández-Miranda I; Pedrosa L; González-Rincón J; Espinet B; de la Cruz Vicente F; Climent F; Gómez S; Royuela A; Camacho FI; Martín-Acosta P et al.
Source: Self-asserted source
Margarita Sanchez-Beato
grade
Preferred source (of 2)‎

CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

Frontiers in Immunology
2024-02-26 | Journal article
DOI: 10.3389/fimmu.2024.1293931
Part of ISSN: 1664-3224
Contributors: Lourdes Hontecillas-Prieto; Daniel J. García-Domínguez; Natalia Palazón-Carrión; Alejandro Martín García-Sancho; Esteban Nogales-Fernández; Carlos Jiménez-Cortegana; María L. Sánchez-León; Silvia Silva-Romeiro; Rocío Flores-Campos; Fernando Carnicero-González et al.
Source: Self-asserted source
Margarita Sanchez-Beato

A genetic profiling guideline to support diagnosis and clinical management of lymphomas

Clinical and Translational Oncology
2023-09-06 | Journal article | Author
DOI: 10.1007/s12094-023-03307-1
Part of ISSN: 1699-3055
Contributors: Margarita Sanchez-Beato; Miriam Mendez; María Guirado; Lucía Pedrosa Pérez; Silvia Sequero-Lopez; Natalia Yanguas Casás; Luis de la Cruz-Merino; Laura Gálvez; Marta Llanos; JUAN F GARCIA et al.
Source: Self-asserted source
Margarita Sanchez-Beato

Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (<i>PSMC</i>) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma

Cancers
2023-01 | Journal article | Author
DOI: 10.3390/cancers15020532
Contributors: Larissa Haertle; Natalia Buenache; Hipólito Nicolás Cuesta Hernández; Michal Simicek; Renata Snaurova; Inmaculada Rapado; Nerea Martinez; Nieves López-Muñoz; José María Sánchez-Pina; Umair Munawar et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Monitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study

Clinical Cancer Research
2022-10-21 | Journal article | Author
DOI: 10.1158/1078-0432.ccr-22-1654
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Contributors: Ismael Fernández-Miranda; Lucía Pedrosa Pérez; Marta Llanos Muñoz; FERNANDO FRANCO; Sagrario Gomez de benito; Paloma Martin-Acosta; FRANCISCO RAMON GARCIA ARROYO; Josep Guma; Beatriz Horcajo ; Ana K Ballesteros et al.
Source: Self-asserted source
Margarita Sanchez-Beato

Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

The Lancet Haematology
2022-06 | Journal article
DOI: 10.1016/s2352-3026(22)00107-7
Part of ISSN: 2352-3026
Source: Self-asserted source
Margarita Sanchez-Beato

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B Cell Lymphoma. Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker subanalysis.

Clinical cancer research : an official journal of the American Association for Cancer Research
2022-06-21 | Journal article
DOI: 10.1158/1078-0432.ccr-22-0588
PMID: 35727601
Contributors: Margarita Sanchez-Beato
Source: Self-asserted source
Margarita Sanchez-Beato

An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy.

EJHaem
2022-05-03 | Journal article | Author
DOI: 10.1002/jha2.457
PMID: 36051055
PMC: PMC9422037
Contributors: Marta Rodriguez Moreno; Alonso-Alonso R; Fernández-Miranda I; Mondéjar R; LAURA CERECEDA; Tráscasa Á; Antonio-Da Conceiçao A; Borregón J; Gato L; Tomás-Roca L et al.
Source: Self-asserted source
Margarita Sanchez-Beato

Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers

Blood Advances
2021-12-28 | Journal article
DOI: 10.1182/bloodadvances.2021005171
Contributors: Marta Rodríguez; Ruth Alonso-Alonso; Laura Tomás-Roca; Socorro M. Rodríguez-Pinilla; Rebeca Manso-Alonso; Laura Cereceda; Jennifer Borregón; Teresa Villaescusa; Raúl Córdoba; Margarita Sánchez-Beato et al.
Source: check_circle
Crossref

PD-1 loss and T-cell exhaustion in CTCL tumoral T cells.

Blood
2021-10-01 | Journal article
DOI: 10.1182/blood.2021012676
PMID: 34618002
Source: Self-asserted source
Margarita Sanchez-Beato

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).

PloS one
2021-09-10 | Journal article
DOI: 10.1371/journal.pone.0257353
PMID: 34506616
PMC: PMC8432772
Source: Self-asserted source
Margarita Sanchez-Beato
grade
Preferred source (of 2)‎

An Overview on Diffuse Large B-Cell Lymphoma Models: Towards a Functional Genomics Approach

Cancers
2021-06-09 | Journal article
DOI: 10.3390/cancers13122893
Contributors: Natalia Yanguas-Casás; Lucía Pedrosa; Ismael Fernández-Miranda; Margarita Sánchez-Beato
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.

Journal for immunotherapy of cancer
2021-06-01 | Journal article
DOI: 10.1136/jitc-2020-002323
PMID: 34158317
Source: Self-asserted source
Margarita Sanchez-Beato

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.

Scientific reports
2021-01-21 | Journal article
DOI: 10.1038/s41598-020-80376-0
PMID: 33479306
PMC: PMC7820010
Source: Self-asserted source
Margarita Sanchez-Beato

Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma.

Blood Cancer Journal
2019-03 | Journal article
DOI: 10.1038/s41408-019-0195-7
PMID: 30858359
PMC: PMC6411728
Contributors: Mata E; Fernández S; Astudillo A; Fernández R; García-Cosío M; Sánchez-Beato M; Provencio M; Estévez M; Montalbán C; Piris MA et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central

Transformed Follicular Lymphoma in the Rituximab Era: A Report from the Spanish Lymphoma Oncology Group.

Hematological oncology
2019-03 | Journal article
DOI: 10.1002/hon.2601
PMID: 30840776
Contributors: Méndez M; Torrente M; Sánchez-Beato M; González-Rincón J; Royuela A; Gómez-Codina J; de la Cruz-Merino L; Rueda A; Llanos M; Quero C et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system.

Haematologica
2019-03-19 | Journal article
DOI: 10.3324/haematol.2018.214981
PMID: 30890596
PMC: PMC6601093
Source: Self-asserted source
Margarita Sanchez-Beato
grade
Preferred source (of 2)‎

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.

PloS one
2019-02 | Journal article
DOI: 10.1371/journal.pone.0212813
PMID: 30802265
PMC: PMC6388933
Contributors: González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia.

Scientific reports
2019-01 | Journal article
DOI: 10.1038/s41598-018-37389-7
PMID: 30700761
PMC: PMC6353992
Contributors: González-Rincón J; Gómez S; Martinez N; Troulé K; Perales-Patón J; Derdak S; Beltrán S; Fernández-Cuevas B; Pérez-Sanz N; Nova-Gurumeta S et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T‐cell lymphoma

British Journal of Haematology
2018-11 | Journal article
DOI: 10.1111/bjh.14984
Contributors: Rebeca Manso; Margarita Sánchez‐Beato; Julia González‐Rincón; Sagrario Gómez; Federico Rojo; Manuela Mollejo; Mónica García‐Cosio; Javier Menárguez; Miguel A. Piris; Socorro M. Rodríguez‐Pinilla
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

Oncotarget
2018-03 | Journal article
DOI: 10.18632/oncotarget.24592
PMID: 29662631
PMC: PMC5882322
Contributors: Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.

Oncotarget
2017-11 | Journal article
DOI: 10.18632/oncotarget.22799
PMID: 29340061
PMC: PMC5762329
Contributors: Mata E; Díaz-López A; Martín-Moreno AM; Sánchez-Beato M; Varela I; Mestre MJ; Santonja C; Burgos F; Menárguez J; Estévez M et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Mutational profile of primary breast diffuse large B-cell lymphoma.

Oncotarget
2017-10 | Journal article
DOI: 10.18632/oncotarget.21986
PMID: 29262531
PMC: PMC5732697
Contributors: Franco F; González-Rincón J; Lavernia J; García JF; Martín P; Bellas C; Piris MA; Pedrosa L; Miramón J; Gómez-Codina J et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.

Oncotarget
2017-07 | Journal article
DOI: 10.18632/oncotarget.19722
PMID: 28938646
PMC: PMC5601742
Contributors: Provencio M; Pérez-Callejo D; Torrente M; Martin P; Calvo V; Gutiérrez L; Franco F; Coronado MJ; Cruz-Bermúdez JL; Ruiz-Valdepeñas AM et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.

PloS one
2017-05 | Journal article
DOI: 10.1371/journal.pone.0177524
PMID: 28505169
PMC: PMC5432176
Contributors: Mondejar R; Pérez C; Onaindia A; Martinez N; González-Rincón J; Pisonero H; Vaqué JP; Cereceda L; Santibañez M; Sánchez-Beato M et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.

2017-04 | Journal article
DOI: 10.1080/10428194.2016.1213829
PMID: 27499002
Contributors: Lozano-Santos C; García-Vela JA; Pérez-Sanz N; Nova-Gurumeta S; Fernandez-Cuevas B; Gomez-Lozano N; Sánchez-Beato M; Sanchez-Godoy P; Bueno JL; Garcia-Marco JA
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Two distinct molecular subtypes of chronic lymphocytic leukemia give new insights on the pathogenesis of the disease and identify novel therapeutic targets.

2016 | Journal article
DOI: 10.3109/10428194.2015.1034706
PMID: 25811675
Contributors: Cordoba R; Sanchez-Beato M; Herreros B; Domenech E; Garcia-Marco J; Garcia JF; Martinez-Lopez J; Rodriguez A; Garcia-Raso A; Llamas P et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

2015-11 | Journal article
DOI: 10.3324/haematol.2015.132837
PMID: 26294736
PMC: PMC4825308
Contributors: Pérez C; González-Rincón J; Onaindia A; Almaráz C; García-Díaz N; Pisonero H; Curiel-Olmo S; Gómez S; Cereceda L; Madureira R et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas.

2015-09 | Journal article
DOI: 10.1016/j.ctrv.2015.05.007
PMID: 26045227
Contributors: Pérez-Callejo D; González-Rincón J; Sánchez A; Provencio M; Sánchez-Beato M
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?

2015-06 | Journal article
DOI: 10.3109/10428194.2014.963576
PMID: 25219591
Contributors: Rubio J; Franco F; Sánchez A; Cantos B; Méndez M; Calvo V; Maximiano C; Perez D; Millán I; Sánchez-Beato M et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.

2015-05 | Journal article
DOI: 10.3324/haematol.2014.117705
PMID: 25552700
PMC: PMC4420232
Contributors: Onaindia A; Gómez S; Piris-Villaespesa M; Martínez-Laperche C; Cereceda L; Montes-Moreno S; Batlle A; de Villambrosia SG; Pollán M; Martín-Acosta P et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.

2015-01 | Journal article
DOI: 10.3324/haematol.2014.113696
PMID: 25304611
PMC: PMC4281331
Contributors: Manso R; Rodríguez-Pinilla SM; González-Rincón J; Gómez S; Monsalvo S; Llamas P; Rojo F; Pérez-Callejo D; Cereceda L; Limeres MA et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

An A91V SNP in the perforin gene is frequently found in NK/T-cell lymphomas.

2014 | Journal article
DOI: 10.1371/journal.pone.0091521
PMID: 24632576
PMC: PMC3954696
Contributors: Manso R; Rodríguez-Pinilla SM; Lombardia L; Ruiz de Garibay G; Del Mar López M; Requena L; Sánchez L; Sánchez-Beato M; Piris MÁ
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

2014 | Journal article
DOI: 10.1371/journal.pone.0112148
PMID: 25386922
PMC: PMC4227704
Contributors: Martín-Sánchez E; Odqvist L; Rodríguez-Pinilla SM; Sánchez-Beato M; Roncador G; Domínguez-González B; Blanco-Aparicio C; García Collazo AM; Cantalapiedra EG; Fernández JP et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

2014-10 | Journal article
DOI: 10.1038/modpathol.2014.34
PMID: 24603590
Contributors: Odqvist L; Montes-Moreno S; Sánchez-Pacheco RE; Young KH; Martín-Sánchez E; Cereceda L; Sánchez-Verde L; Pajares R; Mollejo M; Fresno MF et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature.

2014-05 | Journal article
DOI: 10.1182/blood-2014-02-555946
PMID: 24786457
Contributors: Manso R; Sánchez-Beato M; Monsalvo S; Gómez S; Cereceda L; Llamas P; Rojo F; Mollejo M; Menárguez J; Alves J et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

New drugs and targeted treatments in Hodgkin's lymphoma.

2014-04 | Journal article
DOI: 10.1016/j.ctrv.2013.09.005
PMID: 24095205
Contributors: Provencio M; Sánchez A; Sánchez-Beato M
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

PLCG1 mutations in cutaneous T-cell lymphomas.

2014-03 | Journal article
DOI: 10.1182/blood-2013-05-504308
PMID: 24497536
Contributors: Vaqué JP; Gómez-López G; Monsálvez V; Varela I; Martínez N; Pérez C; Domínguez O; Graña O; Rodríguez-Peralto JL; Rodríguez-Pinilla SM et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.

2014-02 | Journal article
DOI: 10.3324/haematol.2013.096248
PMID: 24497559
PMC: PMC3912951
Contributors: Vaqué JP; Martínez N; Batlle-López A; Pérez C; Montes-Moreno S; Sánchez-Beato M; Piris MA
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.

2013-07 | Journal article
DOI: 10.1038/modpathol.2012.220
PMID: 23429603
Contributors: Arribas AJ; Gómez-Abad C; Sánchez-Beato M; Martinez N; Dilisio L; Casado F; Cruz MA; Algara P; Piris MA; Mollejo M
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

2013-05 | Journal article
DOI: 10.1158/1078-0432.ccr-12-3151
PMID: 23536439
Contributors: Odqvist L; Sánchez-Beato M; Montes-Moreno S; Martín-Sánchez E; Pajares R; Sánchez-Verde L; Ortiz-Romero PL; Rodriguez J; Rodríguez-Pinilla SM; Iniesta-Martínez F et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.

2013-01 | Journal article
DOI: 10.3324/haematol.2012.068510
PMID: 22801959
PMC: PMC3533660
Contributors: Martín-Sánchez E; Rodríguez-Pinilla SM; Sánchez-Beato M; Lombardía L; Domínguez-González B; Romero D; Odqvist L; García-Sanz P; Wozniak MB; Kurz G et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.

2012 | Journal article
DOI: 10.1371/journal.pone.0038158
PMID: 22675518
PMC: PMC3365884
Contributors: Doménech E; Gómez-López G; Gzlez-Peña D; López M; Herreros B; Menezes J; Gómez-Lozano N; Carro A; Graña O; Pisano DG et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.

2012-11 | Journal article
DOI: 10.1158/1541-7786.mcr-12-0335
PMID: 22964433
PMC: PMC3501543
Contributors: Li H; Cai Q; Wu H; Vathipadiekal V; Dobbin ZC; Li T; Hua X; Landen CN; Birrer MJ; Sánchez-Beato M et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas.

2012-08 | Journal article
DOI: 10.1182/blood-2012-05-402784
PMID: 22760782
Contributors: Di Lisio L; Martinez N; Montes-Moreno S; Piris-Villaespesa M; Sanchez-Beato M; Piris MA
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

MicroRNA signatures in B-cell lymphomas.

2012-02 | Journal article
DOI: 10.1038/bcj.2012.1
PMID: 22829247
PMC: PMC3288280
Contributors: Di Lisio L; Sánchez-Beato M; Gómez-López G; Rodríguez ME; Montes-Moreno S; Mollejo M; Menárguez J; Martínez MA; Alves FJ; Pisano DG et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

2012-01 | Journal article
DOI: 10.1038/leu.2011.189
PMID: 21788950
Contributors: Martín-Pérez D; Vargiu P; Montes-Moreno S; León EA; Rodríguez-Pinilla SM; Lisio LD; Martínez N; Rodríguez R; Mollejo M; Castellvi J et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

2012-01 | Journal article
DOI: 10.1182/blood-2011-02-339556
PMID: 22110251
Contributors: Arribas AJ; Campos-Martín Y; Gómez-Abad C; Algara P; Sánchez-Beato M; Rodriguez-Pinilla MS; Montes-Moreno S; Martinez N; Alves-Ferreira J; Piris MA et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎

PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.

2011-11 | Journal article
DOI: 10.1182/blood-2011-03-344374
PMID: 21937691
Contributors: Gómez-Abad C; Pisonero H; Blanco-Aparicio C; Roncador G; González-Menchén A; Martinez-Climent JA; Mata E; Rodríguez ME; Muñoz-González G; Sánchez-Beato M et al.
Source: Self-asserted source
Margarita Sanchez-Beato via Europe PubMed Central
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 3
How many people are using ORCID?